The proportion of CD4+ cells among CTLA-4+ T cells in non-cancerous mucosa was decreased compared to PBMC HNSCC (51.0 ± 18.8% vs. 69.3 ± 14.6%; p < 0.05), but not compared to tumor tissue. The gene discussed is CD4; the disease is head and neck squamous cell carcinoma.